HB3644, the “Blake Burgess Act,” creates a statewide policy framework aimed at improving the prevention, diagnosis, tracking, and treatment of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. It requires hospitals with emergency departments and ambulatory surgical centers to adopt evidence-based policies for VTE risk assessment and treatment, and to train nonphysician clinical staff annually on those procedures. The bill also directs the State Department of Health to contract with the state-designated health information exchange entity to establish and maintain a statewide VTE registry.
Beginning in 2027, hospitals with emergency departments must electronically report specified VTE data to the registry, including patient age, ZIP code, sex, nursing facility or assisted living status, whether the event was fatal, how it was diagnosed, and what treatment was recommended. The Department must also produce a report to legislative and executive leaders analyzing VTE incidence and related inpatient, outpatient, emergency department, and payor data. Registry information may be used or published only for medical research or medical education intended to reduce morbidity or mortality.
The bill also amends the Continuum of Care and Assisted Living Act. It adds statutory definitions for pulmonary embolism and venous thromboembolism, requires resident screening rules to include VTE signs, symptoms, and emergency response techniques, and requires assisted living centers to provide residents a consumer pamphlet about VTE risk factors and warning signs. These changes expand the responsibilities of assisted living centers and the Department of Health in resident education and screening.
Overall, the bill’s impact is to create new reporting, training, and educational duties for hospitals, ambulatory surgical centers, assisted living centers, and the Department of Health, while establishing a new statewide data registry and related public-health reporting structure. It also updates Oklahoma’s assisted living regulations to incorporate VTE awareness into resident assessment and consumer information materials.
The general sentiment appears broadly supportive, with strong committee and floor votes in both chambers, though not unanimous. The bill advanced through committee and floor votes with comfortable margins, suggesting bipartisan interest in addressing a serious and potentially fatal medical condition through prevention and data collection. The emergency clause and July 2026 effective date also indicate a sense of urgency around implementation.
The main points of contention likely center on the added regulatory and reporting burden on hospitals and assisted living facilities, as well as privacy and data-use concerns tied to the statewide registry. The bill limits registry use to research and education, which appears designed to address confidentiality concerns, but the collection of patient ZIP code, sex, residence status, and other health data may still raise questions about administrative burden and data privacy among affected providers.
HB3644 adds new sections to Title 63 requiring hospitals with emergency departments and ambulatory surgical centers to adopt VTE prevention and treatment policies and to train nonphysician personnel annually. It creates a statewide VTE registry administered through a Department of Health contract with the state-designated health information exchange entity, and it imposes annual reporting requirements on hospitals beginning July 1, 2027. The bill also amends the Continuum of Care and Assisted Living Act to add VTE definitions, require VTE screening in resident assessments, and require assisted living centers to provide VTE consumer information pamphlets. These changes affect hospitals, ambulatory surgical centers, assisted living centers, the Department of Health, and the health information exchange entity, while adding new public-health data collection and resident education obligations.
The bill appears to have received generally favorable treatment throughout the legislative process. It passed subcommittee and full committee votes with little opposition, and it advanced on the floor in both chambers with clear majorities. The vote pattern suggests broad agreement that VTE is a significant patient-safety issue and that standardized policies, training, and data collection are appropriate responses. The emergency clause and delayed implementation dates indicate lawmakers viewed the measure as important but still requiring time for facilities and the Department to prepare.
The likely areas of disagreement are the scope of mandated reporting, the administrative burden on hospitals and assisted living centers, and the handling of patient data in the statewide registry. Some legislators or stakeholders may have been concerned about requiring facilities to adopt specific evidence-based protocols, train staff annually, and report detailed patient information, especially where smaller facilities may face compliance costs. Privacy and data-governance concerns may also have been raised because the registry collects identifiable demographic and clinical information, although the bill limits use of registry data to medical research and education aimed at reducing morbidity and mortality.